About Minimally Invasive Surgery
Minimally invasive surgery is a surgical procedure that is performed through tiny incisions instead of a large opening. This surgery is associated with less pain, a shorter hospital stay and fewer complications. There are many minimally invasive surgeries including adrenalectomy, anti-reflux surgery, cancer surgery, colectomy, heart surgery and others. The continuous innovations in minimally invasive surgery making it beneficial for the patient with a wide range of medical conditions.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.21% |
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Minimally Invasive Surgery market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott Laboratories (United States), Zimmer Biomet (United States), Boston Scientific Corporation (United States), CONMED (United States), Aesculap, Inc. (United States), Alphatec Spine, Inc. (United States), AtriCure (United States), CooperSurgical Inc (United States) and DePuy Spine Inc (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are KARL STORZ (Germany), Progressive Medical, Inc. (United States)., Surge-on Medical B.V. (Netherlands), MJ Group (India) and Alphatec Spine Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Minimally Invasive Surgery market by Type (Endoscopic Devices, Electrosurgical Devices and Monitoring and Visualization Devices), Application (Cosmetic Surgery, Cardiac Surgery, Gastrointestinal Surgery and Orthopaedic Surgery) and Region.
On the basis of geography, the market of Minimally Invasive Surgery has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Minimally Invasive Surgery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online Channels will boost the Minimally Invasive Surgery market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increased Research and Development Activities
Market Growth Drivers:
Increased Number of Minimally Invasive Surgery Performed Around the Globe and High Benefits of Minimally Invasive Surgeries
Challenges:
Dearth of Skilled Surgeons
Restraints:
Limited Reimbursement for Surgical Products
Opportunities:
Growth Opportunities in Emerging Markets and Growing Public-Private Initiatives to Support Research Activities on Minimally Invasive Surgical Instruments
Market Leaders and their expansionary development strategies
In October 2023, Hologic, Inc. announced an innovative new partnership with the American Association of Gynecologic Laparoscopists (AAGL) and Inovus Medical. Hologic becomes the chief provider of hysteroscopes for AAGL’s Essentials in Minimally Invasive Gynecologic Surgery (EMIGS) hands-on hysteroscopy skills training for OB-GYN residents.
In March 2024, Intuitive a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company’s next-generation multiport robotic system.
Key Target Audience
Minimally Invasive Surgery Product Providers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.